Bandaríkin - enska - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - phenytoin sodium (unii: 4182431bjh) (phenytoin - unii:6158tkw0c5) - phenytoin sodium 100 mg - extended phenytoin sodium capsules are indicated for the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments (see dosage and administration and clinical pharmacology). extended phenytoin sodium capsules are contraindicated in those patients who are hypersensitive to phenytoin or other hydantoins.

Bandaríkin - enska - NLM (National Library of Medicine)

rxchange co. - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 550 mg - carefully consider the potential benefits and risks of naproxen sodium tablets, usp and other treatment options before deciding to use naproxen sodium tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient's weight. naproxen as naproxen sodium tablets are indicated: • for the relief of the signs and symptoms of rheumatoid arthritis • for the relief of the signs and symptoms of osteoarthritis • for the relief of the signs and symptoms of ankylosing spondylitis • for the relief of the signs and symptoms of juvenile arthritis • for relief of the signs and symptoms of tendonitis • for relief of the signs and symptoms of bursitis • for relief of the signs and symptoms of acute gout • for the management of pain • for the management of primary dysmenorrhea naproxen sodium tablets, usp are contrain

Bandaríkin - enska - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 275 mg - carefully consider the potential benefits and risks of naproxen sodium tablets, usp and other treatment options before deciding to use naproxen sodium tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient's weight. naproxen as naproxen sodium tablets are indicated: • for the relief of the signs and symptoms of rheumatoid arthritis • for the relief of the signs and symptoms of osteoarthritis • for the relief of the signs and symptoms of ankylosing spondylitis • for the relief of the signs and symptoms of juvenile arthritis • for relief of the signs and symptoms of tendonitis • for relief of the signs and symptoms of bursitis • for relief of the signs and symptoms of acute gout • for the management of pain • for the management of primary dysmenorrhea naproxen sodium tablets, usp are contrain

Bandaríkin - enska - NLM (National Library of Medicine)

direct rx - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 550 mg - carefully consider the potential benefits and risks of naproxen sodium tablets, usp and other treatment options before deciding to use naproxen sodium tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient's weight. naproxen as naproxen sodium tablets are indicated: • for the relief of the signs and symptoms of rheumatoid arthritis • for the relief of the signs and symptoms of osteoarthritis • for the relief of the signs and symptoms of ankylosing spondylitis • for the relief of the signs and symptoms of juvenile arthritis • for relief of the signs and symptoms of tendonitis • for relief of the signs and symptoms of bursitis • for relief of the signs and symptoms of acute gout • for the management of pain • for the management of primary dysmenorrhea naproxen sodium tablets, usp are contraind

Bandaríkin - enska - NLM (National Library of Medicine)

rebel distributors corp - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 550 mg - carefully consider the potential benefits and risks of naproxen sodium tablets, usp and other treatment options before deciding to use naproxen sodium tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient's weight. naproxen as naproxen sodium tablets are indicated: • for the relief of the signs and symptoms of rheumatoid arthritis • for the relief of the signs and symptoms of osteoarthritis • for the relief of the signs and symptoms of ankylosing spondylitis • for the relief of the signs and symptoms of juvenile arthritis • for relief of the signs and symptoms of tendonitis • for relief of the signs and symptoms of bursitis • for relief of the signs and symptoms of acute gout • for the management of pain • for the management of primary dysmenorrhea naproxen sodium tablets, usp are contrain

Bandaríkin - enska - NLM (National Library of Medicine)

keltman pharmaceuticals inc. - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 550 mg - carefully consider the potential benefits and risks of naproxen sodium tablets, usp and other treatment options before deciding to use naproxen sodium tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient's weight. naproxen as naproxen sodium tablets are indicated: • for the relief of the signs and symptoms of rheumatoid arthritis • for the relief of the signs and symptoms of osteoarthritis • for the relief of the signs and symptoms of ankylosing spondylitis • for the relief of the signs and symptoms of juvenile arthritis • for relief of the signs and symptoms of tendonitis • for relief of the signs and symptoms of bursitis • for relief of the signs and symptoms of acute gout • for the management of pain • for the management of primary dysmenorrhea naproxen sodium tablets, usp are contrain

Bandaríkin - enska - NLM (National Library of Medicine)

dutch ophthalmic research center (international) b.v. - trypan blue (unii: i2zwo3ls3m) (trypan blue free acid - unii:768n7qo4kh) - trypan blue 0.75 mg in 0.5 ml - membraneblue™ 0.15% is indicated for use as an aid in ophthalmic surgery by staining the epiretinal membranes during ophthalmic surgical vitrectomy procedures, facilitating removal of the tissue. membraneblue™ 0.15% is contraindicated when a non-hydrated (dry state), hydrophilic acrylic intraocular lens (iol) is planned to be inserted into the eye. the dye may be absorbed by the iol and stain it. teratogenic effects: pregnancy category c. trypan blue is teratogenic in rats, mice, rabbits, hamsters, dogs, guinea pigs, pigs, and chickens. the majority of teratogenicity studies performed involve intravenous, intraperitoneal, or subcutaneous administration in the rat. the teratogenic dose is 50 mg/kg as a single dose or 25 mg/kg/day during embryogenesis in the rat. these doses are approximately 4,000- and 2,000-fold the maximum recommended human dose of 0.75 mg per injection based on a 60 kg person, assuming that the whole dose is completely absorved. characteristic anomalies included neural tube, cardiovascular,

Bandaríkin - enska - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 550 mg - carefully consider the potential benefits and risks of naproxen sodium tablets, usp and other treatment options before deciding to use naproxen sodium tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naproxen, usp as naproxen sodium tablets, usp are indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms of acute gout - for the management of pain - for the management of primary dysmenorrhea naproxen sodium tablets, usp are contraindicated in patients with known hypersensitivity to naproxen, usp and naproxen sodium, usp. naproxen sodium, usp should not be given to patie

Bandaríkin - enska - NLM (National Library of Medicine)

west-ward pharmaceuticals corp - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 275 mg - naproxen sodium tablets are indicated for: the relief of the signs and symptoms of:          • rheumatoid arthritis          • osteoarthritis          • ankylosing spondylitis          • polyarticular juvenile idiopathic arthritis naproxen sodium tablets are also indicated for: the relief of signs and symptoms of:          • tendonitis          • bursitis          • acute gout the management of:          • pain          • primary dysmenorrhea naproxen sodium tablets are contraindicated in the following patients:          • known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to naproxen or any components of the drug product [see warnings and precautions (5.7, 5.9) ]          • history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8)]          • in the setting of coronary artery bypass graft (cabg) surgery

Bandaríkin - enska - NLM (National Library of Medicine)

d.o.r.c. dutch ophthalmic research center (international) b.v. - trypan blue (unii: i2zwo3ls3m) (trypan blue free acid - unii:768n7qo4kh) - trypan blue 0.3 mg in 0.5 ml - visionblue® 0.06% is indicated for use as an aid in ophthalmic surgery by staining the anterior capsule of the lens. visionblue® 0.06% is contraindicated when a non-hydrated (dry state), hydrophilic acrylic intraocular lens (iol) is planned to be inserted into the eye. the dye may be absorbed by the iol and stain it. teratogenic effects: pregnancy category c. trypan blue is teratogenic in rats, mice, rabbits, hamsters, dogs, guinea pigs, pigs, and chickens. the majority of teratogenicity studies performed involve intravenous, intraperitoneal, or subcutaneous administration in the rat. the teratogenic dose is 50 mg/kg as a single dose or 25 mg/kg/day during embryogenesis in the rat. these doses are approximately 10,000- and 5,000-fold the maximum recommended human dose of 0.3 mg per injection based in a 60 kg person, assuming that the whole dose is completely absorbed. characteristic anomalies included neural tube, cardiovascular, vertebral, tail, and eye defects. trypan blue also caused an increase in post-im